Table 5.
Meta-analysis of the rate of SAEs, pneumonitis, and drug-related death in combination therapy.
| Studies | Items for evaluation | Rate (%) | 95%CI |
|---|---|---|---|
| Pembro + Chemo in RCT studies | Grade 3-5 TRAEs | 64 | 49-78% |
| Grade 3-5 IRAEs | 10 | 6-14% | |
| Pneumonitis (≥Grade 3) | 4 | 2-6% | |
| Drug-related death | 2 | 1-4% | |
| Pembro in RCT studies | Grade 3-5 TRAEs | 20 | 15-26% |
| Grade 3-5 IRAEs | 9 | 6-12% | |
| Pneumonitis (≥Grade 3) | 3 | 2-4% | |
| Drug-related death | 2 | 0-3% | |
| Pembro + Chemo in Retrospective studies | Grade 3-5 TRAEs | 51 | 40-61% |
| Pneumonitis (≥Grade 3) | 2 | -2-6% | |
| Drug-related death | 2 | -2-6% | |
| Pembro in Retrospective studies | Grade 3-5 IRAEs | 17 | 14-21% |
| Pneumonitis (≥Grade 3) | 3 | 1-5% | |
| Drug-related death | 4 | -2-10% |